By Jim Huang, PhD, Founder & CEO, and Shauket Ali, PhD, Sr. Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
Tremendous progress has been made throughout the years in drug formulations with the launch of new excipients and formulation technologies. However, with an increasing number of new chemical entities (NCEs), challenges remain, and drug manufacturers are open for adapting new technologies to expedite the clinical development and commercialization of these molecules.
With increased regulatory compliances, drug manufactures and contract manufacturers are also taking innovative approaches in designing and developing formulations to reduce pill burden and improve safety and efficacy of drug molecules.
In this article, learn more about the decision for selecting the right and most suited technology for formulating a complex molecule.